Ute Fischer

11PUBLICATIONS
59CO-AUTHORS
Innate immunityMolecular targetsPredictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 07, 2026
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.

Julian Schliehe-Diecks, Jia-Wey Tu, Pawel Stachura

|Dec 06, 2023
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells.

Melina Vogt, Niklas Dienstbier, Julian Schliehe-Diecks

|Sep 20, 2022
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.

Lena Blümel, Nan Qin, Johannes Berlandi

|Jul 13, 2022
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.

Jasmin Bartl, Marco Zanini, Flavia Bernardi

Pageof 2